Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
vardenafil "accord" 5 mg filmovertrukne tabletter
accord healthcare b.v. - vardenafilhydrochloridtrihydrat - filmovertrukne tabletter - 5 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
vardenafil "krka" 10 mg filmovertrukne tabletter
krka d.d. novo mesto - vardenafilhydrochloridtrihydrat - filmovertrukne tabletter - 10 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
vardenafil "krka" 20 mg filmovertrukne tabletter
krka d.d. novo mesto - vardenafilhydrochloridtrihydrat - filmovertrukne tabletter - 20 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
vardenafil "stada" 10 mg filmovertrukne tabletter
stada arzneimittel ag - vardenafilhydrochloridtrihydrat - filmovertrukne tabletter - 10 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
vardenafil "stada" 20 mg filmovertrukne tabletter
stada arzneimittel ag - vardenafilhydrochloridtrihydrat - filmovertrukne tabletter - 20 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
vardenafil "stada" 5 mg filmovertrukne tabletter
stada arzneimittel ag - vardenafilhydrochloridtrihydrat - filmovertrukne tabletter - 5 mg
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
entresto
novartis europharm limited - sacubitril, valsartan - hjertefejl - angiotensin ii antagonister, andre kombinationer, agenter handler på renin-angiotensin systemet - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
fortacin
recordati ireland ltd. - lidocain, prilocaine - seksuel dysfunktion, fysiologisk - anæstesiologi - behandling af primær prematur ejakulation hos voksne mænd.
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
neparvis
novartis europharm limited - sacubitril, valsartan - hjertefejl - agenter, der virker på renin-angiotensinsystemet - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
cetraxal comp 3+0,25 mg/ml øredråber, opløsning
poa pharma scandinavia ab - ciprofloxacin, fluocinolonacetonid - øredråber, opløsning - 3+0,25 mg/ml